Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cerebral vascular smooth muscle cells (VSMCs) are specialized contractile cells that envelope cerebral arteries and arterioles, regulating blood vessel diameter and thus cerebral blood flow. They respond to chemical mediators (e.g., neurotransmitters, hormones), mechanical stimuli, and changes in local metabolic demand by contracting or relaxing, playing a central role in the maintenance of adequate brain perfusion and blood-brain barrier integrity. VSMCs express a variety of receptors (including adrenergic, angiotensin, and endothelin receptors), ion channels, and adhesion molecules, making them responsive to diverse regulatory pathways. Dysfunction or maladaptive phenotypic switching of VSMCs is implicated in multiple cerebrovascular and neurodegenerative diseases.
Inhibition of calcium influx (vasodilation via L-type calcium channel blockade). Adrenergic receptor antagonism or agonism (modulating contraction/relaxation). Modulation of RAS (reducing vasoconstriction by angiotensin II). NO pathway activation (vasodilation via increased NO).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cerebral vascular smooth muscle cell (VSMC).